SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Impact of non-medical switching on clinical and economic outcomes, resource utilization and medication-taking behavior: a systematic literature review
6 references·0 citing·14 second hop
Impact of non-medical switching on clinical and economic outcomes, resource utilization and medication-taking behavior: a systematic literature review (2016)Impact of non-medical switching on clinic…The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses (2014)The Newcastle-Ottawa Scale (N…The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009)The PRISMA statement for repo…The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)The PRISMA Statement for Repo…What do primary care patients think about generic drugs? (2005)What do primary care patients…Guidelines for Therapeutic Interchange—2004: American College of Clinical Pharmacy (2005)Guidelines for Therapeutic In…Prevalence and cost savings of therapeutic interchange among U.S. hospitals (2002)Prevalence and cost savings o…Pharmaceutical Manufacturers Association (1988)Drug substitution in transplantation: A National Kidney Foundation white paper (1999)Estimation of Potential Savings Through Therapeutic Substitution (2016)Measuring inconsistency in meta-analyses (2003)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)Beliefs about generic drugs among elderly adults in hospital-based primary care practices (2008)Generic and therapeutic substitutions in the UK: are they a good thing? (2010)The Effect of an Apparent Change to a Branded or Generic Medication on Drug Effectiveness and Side Effects (2012)Systematic reviews in the social sciences: a practical guide (2006)Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses (2010)ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions (2016)
this work references cited by second hop

References

  • 2009The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration28,382 cited
  • 2009The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration17,725 cited
  • 2014The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses17,633 cited
  • 2005What do primary care patients think about generic drugs?166 cited
  • 2005Guidelines for Therapeutic Interchange—2004: American College of Clinical Pharmacy61 cited
  • 2002Prevalence and cost savings of therapeutic interchange among U.S. hospitals49 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work